Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Freshworks Inc (FRSH) vs Medtronic PLC (MDT) Price & Performance

Freshworks IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Freshworks Inc vs Medtronic PLC — how do they compare? Freshworks Inc trades at $11.58 (market cap $3.31B), while Medtronic PLC trades at $90.79 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 35.1× Freshworks Inc's market cap, and Medtronic PLC pays a 3.18% dividend while Freshworks Inc pays none. Which is the better fit depends on your goals.

FRSHMDT
Market Cap
$3.31B$116.07B
Sector
TechnologyHealth
52-Week High
$13.97$105.35
52-Week Low
$6.88$73.75
Enterprise Value
$2.68B$134.82B
Dividend Yield
3.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Freshworks Inc

Freshworks (FRSH) trades at $11.66, down 2.67% on the day, as the stock consolidates near key technical levels. The company demonstrates strong fundamental improvement with 16% revenue growth in Q2 2026 and achieving GAAP profitability for the first time this year. Recent positive developments include FedRAMP certification progress and Gartner leadership recognition, while analyst sentiment remains evenly split between Buy and Hold ratings with a $16.50 consensus price target representing significant upside potential.

The outlook appears favorable given Freshworks' transition to profitability, expanding AI capabilities, and strong EX business growth. Key risks include competitive pressures in the SaaS sector and the need to maintain recent momentum. With attractive valuation metrics and positive cash flow trends, the stock presents a compelling opportunity for investors seeking exposure to the growing service operations software market.

Medtronic PLC

Medtronic (MDT) trades at $89.99, up 0.65% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, 13.2% net income margin, and positive cash flow trends. Recent product innovations including the Hugo robotic surgery platform and AI surgical tools position MDT for growth. Analyst consensus remains strongly positive with 60% buy ratings and $98.75 price target.

MDT presents a compelling investment case with steady revenue growth, dividend aristocrat status, and technological leadership in medical devices. Key risks include increasing debt levels and competitive pressures from Intuitive Surgical. The stock's current valuation at 24.31 P/E appears reasonable given growth prospects, with upside potential to consensus targets if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Freshworks Inc

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.

Read more on FRSH

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT